Redefining hope from Day One
Nora, living with pLGG since August 2021
We are a growing company of passionate oncologists, scientists, professionals and business leaders unafraid to disrupt the status quo of traditional drug development to get better, targeted medicines faster to patients of all ages who urgently need new options.
Our Search & Development strategy
Our dedicated team has a deep understanding of cancer biology, passion for our patients and a “search & development” strategy that guides us to the right programs for the right patients.
“The people I work with really set Day One apart. My colleagues are smart and talented but also caring and compassionate. They are really great at what they do but also are awesome people. I’ve had the pleasure of seeing the company almost triple in size but it’s amazing to see how the spirit that shaped Day One from the start still guides us today.”
David Lee, Senior Director, Market Planning
Featured
Hear from patients living with pediatric low-grade glioma (pLGG) and their caregivers.
Heather
Mom to a pLGG patient
Bradon
Living with pLGG since age 11
Nora
Living with pLGG since age 7